Skip to main content
logo
Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
28.71
-0.77 (-2.61%)
At close: Oct 13, 2026, 4:00 PM EDT
28.60
-0.11 (-0.38%)
After-hours: Oct 13, 2026, 6:47 PM EDT

Immunovant Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
5,9305,0562,9034,6942,005641
Market Cap Growth
99.76%74.16%-38.16%134.16%212.60%-59.19%
Enterprise Value
5,1324,0612,5284,0041,574117
Last Close Price
29.4824.8417.0932.3115.515.51

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
8.275.934.107.605.531.37
P/TBV Ratio
8.075.934.107.605.531.37

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-0000.000.01
Net Debt / Equity Ratio
-1.08-1.06-1.01-1.03-1.03-1.05
Net Debt / EBITDA Ratio
1.411.691.632.351.803.15
Net Debt / FCF Ratio
1.932.221.902.961.994.62
Quick Ratio
6.828.6810.4213.188.7211.38
Current Ratio
7.279.0911.1613.709.3411.52
Return on Equity (ROE)
-80.10%-64.82%-62.46%-52.91%-50.69%-36.39%
Return on Assets (ROA)
-46.73%-38.43%-37.97%-31.50%-28.26%-21.02%
Return on Capital Employed (ROCE)
-77.00%-62.50%-61.90%-43.70%-57.40%-33.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-9.07%-10.00%-14.26%-5.52%-10.52%-24.44%
FCF Yield
-6.98%-8.06%-12.97%-4.57%-9.40%-16.59%
Buyback Yield / Dilution
-21.12%-20.35%-9.76%-12.21%-12.21%-24.98%
SEC Filings: 10-K · 10-Q